Women pregnant with Covid-19 can give protective antibodies against their child’s coronavirus, study finds
- Researchers in the United States have studied more than 1,700 samples of mother’s and baby’s blood
- Eighty-three of these mothers had coronavirus antibodies in their system
- 72 (8%) of babies born to infected mothers also had Covid antibodies
A new study suggests that pregnant women who have been infected with coronavirus may offer protective antibodies to their unborn baby.
Researchers in Philadelphia have found that Covid antibodies can pass into the placenta of the unborn baby if the mother catches the virus during pregnancy.
The findings are a good sign for concerned future parents, but researchers say they are unable to say with certainty that the newborn of an infected mother is “absolutely safe” from Covid-19 because science is still evolving.
Scroll down for the video

A new study suggests that pregnant women who have been infected with coronavirus may give their babies protective antibodies
The study looked for antibodies in the mother’s blood samples, as well as blood from the umbilical cord – from the placenta and from the attached umbilical cord – immediately after labor.
The blood in the umbilical cord is an exact reflection of the newborn’s blood at birth.
Eighty-three of the 1,471 women in the study, which took place between April 9 and August 8 last year, tested positive for Covid-19, and antibodies were found in the umbilical cord blood of 72 (87%). ) among their babies.
Eleven infants born to Covid-positive mothers who did not have antibodies tested negative for the virus.
“In this cohort study, maternal antibodies to SARS-CoV-2 were transferred across the placenta after asymptomatic and symptomatic infection during pregnancy,” the researchers write in their study, published in JAMA Pediatrics.
The researchers found that the baby inherited more antibodies if the mother had a large number of antibodies, while a mother with only a small number of immune cells would transmit less to her baby.
The corresponding author, Dr. Karen Puopolo, stated: “This finding must be placed in the context of the fact that SARS-CoV-2 is a new virus.
Therefore, the time between exposure to the maternal virus and the birth of the newborn was never more than three to four months in our study, and in most cases the time was shorter than that.
But there must also be enough time between the maternal infection and the birth for the mother to produce the type of antibodies that cross the placenta and for this crossing to take place.
We found that if the time between exposure to the maternal virus and birth was at least two to three weeks, then we could detect antibodies in the newborn.

Philadelphia researchers found that Covid antibodies can pass into the placenta of the unborn baby if the mother catches the virus during pregnancy (stock)
The researchers said their findings support the potential of maternal-derived antibodies to provide protection for their newborns against coronavirus infections.
Dr. Puopolo said: “Our results mean that maternal antibodies to SARS-CoV-2 can cross the placenta effectively, and therefore our results demonstrate the potential for these maternal-derived antibodies to provide neonatal protection against human infection. SARS-CoV-2.
“Nothing in our work should change the way we currently care for pregnant women and their newborns. Our work cannot tell a woman that her newborn is absolutely safe from COVID-19.
“It remains to be seen what levels and types of antibodies protect newborns from SARS-CoV-2 infection and how long these antibodies can last in the newborn’s circulation.”